Close Menu

NEW YORK (GenomeWeb) – Japanese digital technology firm Konica Minolta announced today that it has closed its previously announced acquisition of Ambry Genetics in an all-cash transaction valued at up to $1 billion.

Under the terms of the deal, Konica Minolta's Healthcare Americas subsidiary paid Ambry $800 million up front. Ambry shareholders also stand to receive up to $200 million in incremental consideration based on certain financial metrics over the next few years.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.